HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.

Abstract
We studied the effects of CG-4203, a novel stable prostacyclin analog, in a severe model of traumatic shock in rats. Traumatic shock was produced by Noble Collip drum trauma and was characterized by marked hypotension, a 4- to 5-fold increase in plasma cathepsin D and myocardial depressant factor activities, and survival time of 95 +/- 15 minutes. Treatment with CG-4203 (100 ng/kg/min) significantly prolonged survival time to 194 +/- 20 min (p less than 0.002). Traumatized rats treated with CG-4203 exhibited significantly lower plasma activities of the lysosomal hydrolase cathepsin D (p less than 0.05). Furthermore, the plasma accumulation of myocardial depressant factor (MDF) activity was also significantly blunted in traumatized CG-4203 treated rats when compared with traumatized rats receiving only the vehicle (p less than 0.01). Our results suggest that a combination of membrane stabilizing and anti-proteolytic effects and inhibition of platelet aggregation may mediate the protective effects of CG-4203 in traumatic shock.
AuthorsH Bitterman, G L Stahl, A M Lefer
JournalProstaglandins (Prostaglandins) Vol. 35 Issue 1 Pg. 41-50 (Jan 1988) ISSN: 0090-6980 [Print] United States
PMID3287456 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Myocardial Depressant Factor
  • taprostene
  • Epoprostenol
  • Cathepsin D
Topics
  • Animals
  • Blood Pressure (drug effects)
  • Cathepsin D (blood)
  • Disease Models, Animal
  • Epoprostenol (therapeutic use)
  • Lysosomes (enzymology)
  • Male
  • Myocardial Depressant Factor (blood)
  • Rats
  • Rats, Inbred Strains
  • Reference Values
  • Shock, Hemorrhagic (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: